Grace Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $25.9M | $36.9M | $16.9M |
| FY2020 | $9.9M | $22.9M | $14.2M |
| FY2021 | $6.8M | $62.5M | $50.9M |
| FY2022 | $20.4M | $128.6M | $30.3M |
| FY2023 | $11.2M | $79.1M | $27.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $25.9M | $36.9M | $16.9M |
| FY2020 | $9.9M | $22.9M | $14.2M |
| FY2021 | $6.8M | $62.5M | $50.9M |
| FY2022 | $20.4M | $128.6M | $30.3M |
| FY2023 | $11.2M | $79.1M | $27.9M |